Dissociation between hippocampal neuronal loss, astroglial and microglial reactivity after pharmacologically induced reverse glutamate transport

Neurochemistry International

Volumn 49, Issue 7, 2006, Pages 691-697

  de Yebra, Lluïsa ^a   Malpesa, Yolanda ^a   Ursu, Gloria ^a   Pugliese, Marco ^a   Liévens, Jean Charles ^b   Goff, Lydia Kerkerian Le ^b   Mahy, Nicole ^a  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^b CNRS   (France)

Author keywords

Astrogliosis; Calcium precipitation; Central nervous system; Glutamate transport; Hippocampus; l Trans pyrrolidine 2,4 dicarboxylate (PDC); Microgliosis; Neuronal death; Rat

Indexed keywords

2,4 PYRROLIDINEDICARBOXYLIC ACID; CALCIUM; GLUTAMIC ACID;

AMINO ACID TRANSPORT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; ASTROCYTOSIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; GLIOSIS; HIPPOCAMPUS; MACROGLIA; MALE; MICROGLIA; MOLECULAR INTERACTION; NERVE CELL DEGENERATION; NERVE CELL NECROSIS; NEUROBIOLOGY; NEUROPHARMACOLOGY; NEUROPROTECTION; NONHUMAN; PRECIPITATION; PRIORITY JOURNAL; RAT;

AMINO ACID TRANSPORT SYSTEM X-AG; ANIMALS; ASTROCYTES; CALCIUM; CALCIUM SIGNALING; CELL DEATH; DICARBOXYLIC ACIDS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENCEPHALITIS; GLIOSIS; GLUTAMIC ACID; HIPPOCAMPUS; MALE; MICROGLIA; NERVE DEGENERATION; NEUROGLIA; NEURONS; NEUROTRANSMITTER UPTAKE INHIBITORS; PYRROLIDINES; RATS; RATS, WISTAR;

EID: 33750010360     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2006.06.008     Document Type: Article

References (42)

1. Akiyama H., Barger S., Barnum S., Bradt B., Bauer J., Cole G.M., Cooper N.R., Eikelenboom P., Emmerling M., Fiebich B.L., Finch C.E., Frautschy S., Griffin W.S., Hampel H., Hull M., Landreth G., Lue L., Mrak R., Mackenzie I.R., McGeer P.L., O'Banion M.K., Pachter J., Pasinetti G., Plata-Salaman C., Rogers J., Rydel R., Shen Y., Streit W., Strohmeyer R., Tooyoma I., Van Muiswinkel F.L., Veerhuis R., Walker D., Webster S., Wegrzyniak B., Wenk G., and Wyss-Coray T. Inflammation and Alzheimer's disease. Neurobiol. Aging 21 (2000) 383-421
2. Amara S.G., and Fontana A.C.K. Excitatory amino acid transporters: keeping up with glutamate. Neurochem. Int. 41 (2002) 313-318
3. Batchelor P.E., Porritt M.J., Martinello P., Parish C.L., Liberatore G.T., Donnan G.A., and Howells D.W. Macrophages and microglia produce local trophic gradients that stimulate axonal sprouting toward but not beyond the wound edge. Mol. Cell. Neurosci. 21 (2002) 436-453
4. Bernal F., Andrés N., Samuel D., Kerkerian-LeGoff L., and Mahy N. Age-related resistance to α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid-induced hippocampal lesion. Hippocampus 10 (2000) 296-304
5. Bernal F., Saura J., Ojuel J., and Mahy N. Differential vulnerability of hippocampus, basal ganglia and prefrontal cortex to long-term NMDA excitotoxicity. Exp. Neurol. 161 (2000) 686-695
6. Bonanno G., Pittaluga A., Fedele E., Fontana G., and Raiteri M. Glutamic acid and gamma-aminobutyric acid modulate other's release through heterocarriers sited on the axon terminals of rat brain. J. Neurochem. 61 (1993) 222-230
7. Chretien F., Vallat-Decouvelaere A.V., Bossuet C., Rimaniol A.C., Le Grand R., Le Pavec G., Créminon C., Dormont D., Gray F., and Gras G. Expression of excitatory amino acid transporter-2 (EAAT-2) and glutamine synthetase (GS) in brain macrophages and microglia of SIVmac251-infected macaques. Neuropathol. Appl. Neurobiol. 28 (2002) 410-417
8. Danbolt N.C. Glutamate uptake. Prog. Neurobiol. 65 (2001) 1-105
9. Dunlop J., Zaleska M.M., Eliasof S., and Moyer J.A. Excitatory amino acid transporters as emerging targets for central nervous system therapeutics. Emerg. Ther. Targets 3 (1999) 543-570
10. Eyüpoglu I.Y., Bechmann I., and Nitsch R. Modification of microglia function protects from lesion-induced neuronal alterations and promotes sprouting in the hippocampus. FASEB J. (2003)
11. González-Scarano F., and Baltuch G. Microglia as mediators of inflammatory and degenerative diseases. Annu. Rev. Neurosci. 22 (1999) 219-240
12. Hohlfeld R., Kerschensteiner M., Stadelmann C., Lassmann H., and Wekerle H. The neuroprotective effect of inflammation: implications for the therapy of multiple sclerosis. J. Neuroimmunol. 107 (2000) 161-166
13. Kreutzberg G.W. Microglia:a sensor for pathological events in the CNS. Trends Neurosci. 19 (1996) 312-318
14. Liévens J.C., Bernal F., Forni C., Mahy N., and Kerkerian-LeGoff L. Characterization of striatal lesions produced by glutamate uptake alteration: cell death, reactive gliosis and changes in GLT1 and GADD45 mRNA expression. Glia 29 (2000) 222-232
15. Liévens J.C., Dutertre M., Forni C., Salin P., and Kerkerian-LeGoff L. Continuous administration of the glutamate uptake inhibitor l-trans-pyrrolidine-2,4-dicarboxylate produces striatal lesion. Mol. Brain Res. 50 (1997) 181-189
16. Lopez-Redondo F., Nakajima K., Honda S., and Kohsaka S. Glutamate transporter GLT-1 is highly expressed in activated microglia following facial nerve axotomy. Brain Res. Mol. Brain Res. 76 (2000) 429-435
17. Mahley R.W., and Rall Jr. S.C. Apolipoprotein E: far more than a lipid transport protein. Annu. Rev. Genomics Hum. Genet. 1 (2000) 507-537
18. Mahy N., Bendahan G., Boatell M.L., Bjelke B., Tinner B., Olson L., and Fuxe K. Differential brain area vulnerability to long-term subcortical excitotoxic lesions. Neuroscience 65 (1995) 15-25
19. Medzhitov R., and Janeway Jr. C. Advances in immunology: innate immunity. N. Engl. J. Med. 343 (2000) 338-344
20. Minghetti L., and Levi G. Microglia as effector cells in brain damage and repair: focus on prostanoids and nitric oxide. Prog. Neurobiol. 54 (1998) 99-125
21. O'Shea R.D. Roles and regulation of glutamate transporters in the central nervous system. Clin. Exp. Pharmacol. Physiol. 29 (2002) 1018-1023
22. Paxinos G., and Watson C. The rat Brain in Stereotaxic Coordinates (1986), Academic Press, San Diego
23. Petegnief V., Saura J., Dewar D., Cummins D.J., Dragunow M., and Mahy N. Long-term effects of α-amino-3-hydroxy-5-methyl-4-isoxazole propionate and 6-nitro-7-sulphamoylbenzo(f)quinoxaline-2,3-dione in the rat basal ganglia: calcification, changes in glutamate receptors and glial reactions. Neuroscience 94 (1999) 105-115
24. Qin S., Colin C., Hinners I., Gervais A., Cheret C., and Mallat M. System Xc- and apolipoprotein E expressed by microglia have opposite effects on the neurotoxicity of amyloid-beta peptide 1-40. J. Neurosci. 26 (2006) 3345-3356
25. Raiteri L., Raiteri M., and Bonanno G. Coexistence and function of different neurotransmitter transporters in the plasma membrane of CNS neurons. Prog. Neurobiol. 68 (2002) 309-387
26. Ramonet D., Pugliese M., Rodríguez M.J., De Yebra L., Andrade C., Adroer R., Ribalta T., Mascort J., and Mahy N. Calcium precipitation in acute and chronic brain diseases. J. Physiol. Paris 96 (2002) 307-312
27. Ramonet D., Rodríguez M.J., Fredriksson K., Bernal F., and Mahy N. In vivo neuroprotective adaptation of the glutamate/glutamine cycle to neuronal death. Hippocampus 14 (2004) 586-594
28. Robinson M.B., and Dowd L.A. Heterogeneity and functional properties of subtypes of sodium-dependent glutamate transporters in the mammalian central nervous system. Adv. Pharmacol. 37 (1997) 69-115
29. Robledo P., Ursu G., and Mahy N. Effects of adenosine and gamma-aminobutyric acid A receptor antagonists on N-methyl-d-aspartate induced neurotoxicity in the rat hippocampus. Hippocampus 9 (1999) 527-533
30. Rodríguez M.J., Bernal F., Andrés N., Malpesa Y., and Mahy N. Excitatory amino acids and neurodegeneration: an hypothetical role of calcium precipitation. Int. J. Dev. Neurosci. 18 (2000) 299-307
31. Rothstein J.D., Dykes-Hoberg M., Pardo C.A., Bristol L.A., Jin L., Kuncl R.W., Kanai Y., Hediger M.A., Wang Y., Schielke J.P., and Welty D.F. Knockout of glutamate transporters reveals a major role for astroglial transport in ecitotoxicity and clearance of glutamate. Neuron 16 (1996) 675-686
32. Saura J., Boatell M.L., Bendahan G., and Mahy N. Calcium deposits formation and glial reaction in rat brain after ibotenic acid-induced basal forebrain lesions. Eur J. Neurosci. 7 (1995) 1569-1578
33. Sánchez-Carbente M.d.R., and Massieu L. Transient inhibition of glutamate uptake in vivo induces neurodegeneration when energy metabolism is impaired. J. Neurochem. 72 (1999) 129-138
34. Schwartz M., Shaked I., Fisher J., Mizrahi T., and Schori H. Protective autoimmunity against the enemy within: fighting glutamate toxicity. Trends Neurosci. 26 (2003) 297-302
35. Seputki J., Eccles C.U., Lesser R.P., Dykes-Hoberg M., and Rothstein J.D. Molecular knockdown of neuronal glutamate transporter EAAT3 produces epilepsy and dysregulation of GABA metabolism. Neuroscience Meeting Abstract 23 (1997) 581.1
36. Streit W.J., Mark R., and Griffin S. Microglia and neuroinflammation: a pathological perspective. J. Neuroinflam. 1 (2004) 14-17
37. Streit W.J., Walter S.A., and Pennell N.A. Reactive microgliosis. Prog. Neurobiol. 57 (1999) 563-581
38. Trotti D., Danbolt N.C., and Volterra A. Glutamate transporters are oxidant-vulnerable: a molecular link between oxidative and excitotoxic neurodegeneration?. Trends Pharmacol. Sci. 19 (1998) 328-334
39. Vallat-Decouvelaere A.V., Chretien F., Gras G., Le Pavec G., Dormont D., and Gray F. Expression of excitatory amino acid transporter-1 in brain macrophages and microglia of HIV-infected patients. A neuroprotective role for activated microglia?. J. Neuropathol. Exp. Neurol. 62 (2003) 475-485
40. van Landeghem F.K.H., Stover J.F., Bechmann I., Brück W., Unterberg A., Bührer C., and von Deimling A. Early expression of glutamate transporter proteins in ramified microglia after controlled cortical impact injury in the rat. Glia 35 (2001) 167-179
41. Watanabe H., Abe H., Takeuchi S., and Tanaka R. Protective effect of microglial conditioning medium on neuronal damage induced by glutamate. Neurosci. Lett. 289 (2000) 53-56
42. Zuiderwijk M., Veenstra E., Lopes da Silva F.H., and Ghijsen W.E.J.M. Effects of uptake carrier blockers SK&F89976-A and l-trans-PDC on in vivo release of amino acids in rat hippocampus. Eur. J. Pharmacol. 307 (1996) 275-282